CERO THERAPEUTICS HOLDINGS, INC. Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions of 50.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Equity
us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions · last filed 2026-04-15
- CERO THERAPEUTICS HOLDINGS, INC. subsidiary or equity method investee, cumulative percentage ownership after all transactions for fiscal 2025 was 50.00%.
| Period end | Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions 11 month | Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions 12 month |
|---|---|---|
| 2025-12-31 | 50.00% 10-K · filed 2026-04-15 | |
| 2024-12-31 | 50.00% 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |